Srijoy Mahapatra
Cardiovascular Disease · Rochester, MNNPI 1295715282
Payments from drug & device makers
What this record shows
This record is dominated by other: $818,645 of the $1,188,673 with a category attached, or 68.9%. Medtronic accounts for 68.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $625,424 and has fallen 100.0% since, to $127 in 2025. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $8740.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$819K
- Atricure, Inc.$271K
- Abbott$98K
- Acutus Medical, Inc.$193
- Biotronik Inc.$135
- Pulse Biosciences, Inc.$127
- plus $196 from 3 others
Across 2 payments — averaging $392,428 each. An ownership or investment interest held by the physician or an immediate family member.
- Anumana, Inc.$785K
What the payments were for
- Consulting fees$354,34130%
- Speaking & faculty fees$5,0000%
- Travel & lodging$8,2721%
- Food & beverage$2,4160%
- Other$818,64569%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 9 | $818,760 |
| Atricure, Inc. | 60 | $271,170 |
| Abbott | 61 | $98,093 |
| Acutus Medical, Inc. | 1 | $193 |
| Biotronik Inc. | 1 | $135 |
| Pulse Biosciences, Inc. | 1 | $127 |
| Boston Scientific | 1 | $99 |
| Abiomed | 1 | $61 |
| KCI USA, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYS$191,011
- ATRICLIP LAA EXCLUSION SYSTEM$69,815
- TactiCath Quartz CFA Catheter$40,668
- Ensite Cardiac Mapping System$32,892
- AMPLATZER Occluders$5,773
- SYNERGY ABLATION SYSTEM$5,525
- Cardiovascular- Research only$5,000
- AMPLATZER$5,000
- Therapy Ablation Catheter$4,750
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$3,131
- EnSite Precision Cardiac Mapping System$2,000
- Neuromodulation Dspsbls and Accs$1,000
- Accent Pacemaker$146
- CellFX$127
How this compares
$1,188,673 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.
Other cardiovascular disease in Rochester
- Charanjit RihalRochester$478K
- Amir LermanRochester$465K
- Martha GroganRochester$330K
- Virend SomersRochester$262K
- Francisco Lopez-JimenezRochester$167K
- Ammar KilluRochester$139K
- Allan JaffeRochester$111K
- Robert McBaneRochester$110K
- Michael McGoonRochester$106K
- R Scott WrightRochester$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.